युनियन बँक ऑफ इंडियाला एबीसीआयद्वारे ९ पुरस्कारांनी सन्मानित

-

    युनियन बँक ऑफ इंडियाला एबीसीआयद्वारे ९ पुरस्कारांनी सन्मानित


मुंबई, ०६ डिसेंबर २०२०: युनियन बँक ऑफ इंडियाला मुंबई येथील इंडियन मर्चंट चेंबर्स येथे आज विविध गटात असोसिएशन ऑफ बिझनेस कम्युनिकेटर्स ऑफ इंडिया (एबीसीआय) तर्फे चँपियन ऑफ चँपियनसह ९ पुरस्कार मिळाले. बँकेचे त्रैमाकसिक कॉर्पोरेट हाऊस मॅगझीन “‘युनियन धारा’’ आणि हिंदी हाऊस मॅगझीन ‘‘ युनियन श्रीजन”साठी हे पुरस्कार मिळाले.


एबीसीआयचे प्रमुख पाहुणे प्रशांत करुलकर यांच्याकडून युबीआयचे एक्झिक्युटिव्ह डायरेक्टर मानस रंजन बिसवाल यांनी हे पुरस्कार स्वीकारले.  त्यांच्यासोबत चीफ जनरल मॅनेजर ब्रजेश्वर शर्मा, चीफ जनरल मॅनेजर कल्याण कुमार, डेप्युटी जनरल मॅनेजर (अधिकृत भाषा) अंबरीश कुमार सिंग आणि एडिटर युनियन धारा आणि युनियन श्रीजन, डॉ. सुलभा कोरे हेदेखील कार्यक्रमात उपस्थित होते.


अंतर्गत मासिक, भारतीय भाषिक प्रकाशन, द्वैभाषिक प्रकाशन, विशेष स्तंभ (इंग्रजी), फीचर्स (भाषा), विशेष स्तंभ (भाषा), फोटोग्राफी, फोटो फीचर आणि इल्युस्ट्रेशन अशा विविध गटांमध्ये बँकेला १ सुवर्ण, ४ रौप्य आणि ४ कांस्य पदक मिळाले. सर्वात मोठा पुरस्कार विजेता असल्याने युनियन बँक ऑफ इंडियाला चँपियन ऑफ चँपियनची ट्रॉफी मिळाली.

For further information: Sachin Kulaye 9867036368, Value360 Commu

Comments

Post a Comment

Popular posts from this blog

Indegene acquires Trilogy Writing & Consulting GmbH, a medical writing consultancy

-
  Indegene acquires Trilogy Writing & Consulting GmbH,  a medical writing consultancy   India, March 27, 2024:  Indegene, a  digital-first, life sciences commercialization company , announced the acquisition of Trilogy Writing & Consulting GmbH (Trilogy), a global provider of specialty medical writing capabilities across clinical, regulatory, safety and medical content to life sciences companies. The acquisition by Indegene Ireland, a subsidiary of Indegene Limited, augments Indegene’s depth of clinical and regulatory writing expertise for market authorization applications globally.   Trilogy Writing & Consulting is a Germany, UK, and US-based, medical writing consultancy with know-how in the development and delivery of clinical, regulatory, safety, and medical content. It applies its expertise and unique approaches to deliver quality medical writing output. Trilogy has a proven track record of more than 22 years of providing medical writing services to the biopharmaceutica
Read more

TiEcon Mumbai 2023, brilliantly showcased revolutionary ideas & impactful solutions to build an Anti-Fragile and Sustainable India

-
Image
TiEcon Mumbai 2023, brilliantly showcased revolutionary ideas & impactful solutions to build an Anti-Fragile and Sustainable India Mumbai, 09 June 2023 : The 16th Edition of TiEcon Mumbai, organised by TiE Mumbai at Jio Convention Centre, BKC culminated on an enthusiastic note with a call to build an Anti-Fragile and Sustainable India. It kick-started with marquee speakers focusing on ways to accelerate growth, drive more intelligent engagement, make conscious choices and methods to empower sustainable business building ideas. Speaking at the summit, Ranu Vohra, President- TiE Mumbai said, “It was great to see the energy of the startup eco system at work at TiECon 2023. There were lively debates on Mumbai’s roadmap to becoming the startup hub, Gen AI and its role in India and the opportunities, thus created. The session on funding availability held out promise that as the startups become “anti-fragile” and focus on unit economics and profitability we should see a renewed incre
Read more

REC DECLARES ITS FINANCIAL RESULTS FOR Q2 & H1 FY24

-
REC DECLARES ITS FINANCIAL RESULTS FOR Q2 & H1 FY24   REC RECORDS ITS HIGHEST EVER QUARTERLY PROFIT AT ₹3,773 CRORE Mumbai/New Delhi, November 01, 2023: REC limited, a ‘Maharatna’ company under the administrative control of the Ministry of Power, Government of India, and registered with RBI as Non-Banking Finance Company (NBFC), Public Financial Institution (PFI) and Infrastructure Financing Company (IFC), has today reported its unaudited financial results (Standalone) for the 2nd Quarter and Half Year ended 30th September 2023. Key highlights are as under:  Operational and Financial Highlights –Q2 FY24 vs Q2 FY23 (Standalone) • Sanctions: ₹ 1,04,366 crore vs. ₹ 84,889 crore, up 23%, Renewable sector constitutes for 24% • Disbursements: ₹ 41,598 crore vs. ₹ 17,827 crore, up 133% • Interest Income on Loan Assets: ₹ 11,213 crore vs. ₹ 9,534 crore, up 18% • Net Profit: ₹ 3,773 crore vs. ₹ 2,728 crore, up 38% • Total Comprehensive Income: ₹ 4,188 crore vs. ₹ 1,915 crore, up 1
Read more